John R. Mehall

John R. Mehall is the current HALO Dx Fellow at HALO Diagnostics. Before that, they were the President of Peak Perfusion Group from January 2015 to April 2019. John also worked as the National Cardiovascular Service Line at Catholic Health Initiatives from April 2013 to August 2020 and as the Chief of Cardiac Surgery at Centura Health from July 2010 to August 2020. Additionally, Mehall has experience with Edwards Lifesciences and was the President, CEO of CV Staff Solutions from December 2013 to April 2019. Lastly, they have worked with Cardiac & Thoracic Surgery Associates, PC and Cardiac and Thoracic Surgery Associates.

John R. Mehall received their MBA from The University of Texas at Dallas, a Value Measurement in Healthcare from Harvard Business School, an MD in Medicine from The University of Texas Medical School at Houston, a BS / BA in Biology / Philosophy from Southern Methodist University, and a Philosophy from Yale University.